What does CUSIP 25456J104 represent in this 13F holders report?

CUSIP 25456J104 is the security identifier for DPRX - DIPEXIUM PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in Q4 2016?

15 institutional investors reported DPRX - DIPEXIUM PHARMACEUTICALS INC - COM for Q4 2016. Use the holders table for investor-level position and value details.

DIPEXIUM PHARMACEUTICALS INC - COM (DPRX)

CUSIP: 25456J104

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / COM
Total 13F shares: 330,219
Share change: -2,044,131
Total reported value: $526,800
Price per share: $1.60
Number of holders: 15
Value change: -$29,243,339
Number of buys: 8
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 25456J104:

Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015

Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q4 2016

As of 31 Dec 2016, DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 330,219 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, Acrospire Investment Management LLC, BlackRock Fund Advisors, Middleton & Co Inc/MA, Bank of New York Mellon Corp, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.